BDBM571591 (1R,3S,5R)-2-(2-(3-acetyl- 7-methyl-1H-indazol-1- yl)acetyl)-N-(6-bromo-3- methylpyridin-2-yl)-5- ((2,2-difluorocyclopentane- 1-carboxamido)methyl)-2- azabicyclo[3.1.0]hexane-3- carboxamide::US11447465, Cmp No. T-43

SMILES CC(=O)c1nn(CC(=O)N2[C@@H]3C[C@]3(CNC(=O)C3CCCC3(F)F)C[C@H]2C(=O)Nc2nc(Br)ccc2C)c2c(C)cccc12

InChI Key InChIKey=LYBICAXJKUGKQL-UHFFFAOYSA-N

Data  1 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 571591   

TargetComplement factor D(Human)
Achillion Pharmaceuticals

US Patent
LigandPNGBDBM571591((1R,3S,5R)-2-(2-(3-acetyl- 7-methyl-1H-indazol-1- ...)
Affinity DataIC50: 1.00E+3nMAssay Description:Human Factor D (purified from human serum, Complement Technology, Inc.) at 80 nM final concentration is incubated with test compound at various conce...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/19/2022
Entry Details
US Patent